8-K: Iveda Solutions Enters Into $5 Million At-the-Market Offering Agreement

Iveda Solutions, Inc. has entered into an agreement with H.C. Wainwright & Co., LLC to sell up to $5,082,431 of its common stock through an at-the-market offering.

Summary

• Iveda Solutions, Inc. has entered into an At the Market Offering Agreement with H.C. Wainwright & Co., LLC, dated February 27, 2025.
• Under the agreement, Iveda may offer and sell shares of its common stock, with an aggregate offering price of up to $5,082,431.
• Sales will be made through or to the Sales Agent, H.C. Wainwright & Co., LLC, from time to time.
• The company will pay a commission rate of 3% of the gross sales price per share sold.
• Iveda will also reimburse the Sales Agent for certain specified expenses, including legal counsel fees up to $50,000 and due diligence update session fees up to $5,000 per session.
• The offering will be made pursuant to the company's effective shelf registration statement on Form S-3.
• Iveda is not obligated to make any sales of Placement Shares under the Sales Agreement and the Company cannot provide any assurances that it will issue any Placement Shares pursuant to the Sales Agreement.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The announcement is a standard financial transaction (ATM offering). While it provides the company with potential capital, it also introduces risks of dilution and market volatility.

Positives

• The At the Market Offering Agreement provides Iveda Solutions with a flexible way to raise capital.
• The company is not obligated to sell any shares, allowing it to take advantage of favorable market conditions.
• The offering is made under an existing shelf registration statement, which simplifies the process.

Negatives

• The company will incur commission and expense reimbursement costs.
• There is no guarantee that the company will be able to sell all of the shares it intends to offer.
• The sale of shares may dilute existing shareholders' ownership.

Risks

• Market conditions may not be favorable for selling shares.
• The company may not be able to find buyers for all of the shares it intends to offer.
• The sale of shares may dilute existing shareholders' ownership.
• The company's stock price could be negatively impacted by the offering.

Future Outlook

The company may offer and sell shares of its common stock from time to time, but there is no assurance that it will issue any shares pursuant to the Sales Agreement.

Industry Context

At-the-market offerings are a common way for companies to raise capital, particularly for smaller companies or those with volatile stock prices. This type of offering allows companies to sell shares into the market over time, which can help to minimize dilution and avoid large price swings.

Comparison to Industry Standards

• Comparable companies that have used ATM offerings include those in similar technology sectors seeking flexible funding options.
• The 3% commission is within the typical range for ATM offerings, which can vary based on the size of the offering and the sales agent involved.
• The legal and due diligence expense reimbursements are also standard in these types of agreements.

Legal Proceedings

• Aegis Capital Corp. filed a Summons and Complaint against the Company on or about September 13, 2024.
• Aegis alleges the Company is obligated to pay Aegis fees in an amount not less than $300,000 from an offering of the Company's securities on September 5, 2024.
• The Company terminated the Letter for non-performance prior to the Offering on August 15, 2024 and is defending the action vigorously.

Stakeholder Impact

• Shareholders may experience dilution if the company sells a significant number of shares.
• The company's employees and customers may benefit from the additional capital raised through the offering.
• The company's creditors may be impacted by the offering, depending on how the proceeds are used.

Next Steps

• Iveda Solutions may choose to offer and sell shares of its common stock through the Sales Agent.
• H.C. Wainwright & Co., LLC will use commercially reasonable efforts to sell the Placement Shares based upon the Company's instructions.
• The Company will file a Prospectus Supplement with the Commission.

Key Dates